Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
439.37
+14.38 (3.38%)
At close: May 12, 2025, 4:00 PM
439.33
-0.04 (-0.01%)
After-hours: May 12, 2025, 6:37 PM EDT
Vertex Pharmaceuticals Analyst Ratings
Total Analysts
26
Consensus Rating
Buy
Price Target
$512.54
Upside
+16.65%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $420 → $423 | Hold | Maintains | $420 → $423 | -3.73% | May 6, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $450 → $442 | Hold | Maintains | $450 → $442 | +0.60% | May 6, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $462 → $464 | Hold | Maintains | $462 → $464 | +5.61% | May 6, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $512 → $515 | Buy | Maintains | $512 → $515 | +17.21% | May 6, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $535 | Buy | Reiterates | $535 | +21.77% | May 6, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 6, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $550 → $503 | Buy → Hold | Downgrades | $550 → $503 | +14.48% | May 6, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $535 | Buy | Initiates | $535 | +21.77% | Apr 22, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $408 → $420 | Hold | Maintains | $408 → $420 | -4.41% | Apr 1, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $555 → $567 | Strong Buy | Maintains | $555 → $567 | +29.05% | Mar 31, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $407 → $408 | Hold | Maintains | $407 → $408 | -7.14% | Feb 20, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Sell → Hold Upgrades $408 → $424 | Strong Sell → Hold | Upgrades | $408 → $424 | -3.50% | Feb 12, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $460 → $520 | Strong Buy | Maintains | $460 → $520 | +18.35% | Feb 11, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $402 → $407 | Hold | Maintains | $402 → $407 | -7.37% | Feb 11, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $433 → $450 | Hold | Maintains | $433 → $450 | +2.42% | Feb 11, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $480 | Buy | Reiterates | $480 | +9.25% | Feb 11, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.